/

Electronics & Software

/

Otsuka Pharmaceutical Companies Europe

Otsuka Pharmaceutical Companies Europe

Otsuka Pharmaceutical Companies Europe

Verified Nov 2026

Electronics & Software

·

United Kingdom flag

Slough, England

·

Since 1979

Otsuka Pharmaceutical Europe Ltd. is the European regional headquarters for Japan-based Otsuka Pharmaceutical Co., Ltd., operating from Slough, England since its UK establishment in 1998. The private company employs 500–1,000 staff and generates estimated revenues of $250–500M annually. It develops and distributes pharmaceuticals, nutraceutical products, and clinical nutrition solutions across Europe, focusing on cardiovascular, gastrointestinal, and central nervous system disorders. In January 2026, the company obtained European Union marketing authorization for donidalorsen to treat hereditary angioedema.

Otsuka Pharmaceutical Companies Europe

Verified Nov 2026

AT A GLANCE

Founded

1979

Headquarters

United Kingdom flag

Slough, England

Employees

500-1,000

Ownership

Otsuka Pharmaceutical Companies Europe at a glance

Revenue

$250-500M

Est. band

Employees

500-1,000

Founded

1979

Headquarters

Slough, England

Certifications

ISO 13485 · ISO 14001 · ISO 9001

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

STABILITY SIGNALS

Established & active

47 years in operation (founded 1979).

Holds ISO 13485, ISO 14001, ISO 9001 certification(s) per public sources.

Overview

Otsuka Pharmaceutical Europe Ltd. is the European regional headquarters for Japan-based Otsuka Pharmaceutical Co., Ltd., operating from Slough, England since its UK establishment in 1998. The private company employs 500–1,000 staff and generates estimated revenues of $250–500M annually. It develops and distributes pharmaceuticals, nutraceutical products, and clinical nutrition solutions across Europe, focusing on cardiovascular, gastrointestinal, and central nervous system disorders. In January 2026, the company obtained European Union marketing authorization for donidalorsen to treat hereditary angioedema.

At a glance

Attribute

Detail

Founded

1979

Headquarters

Slough, England

Employees

500-1,000

Revenue

$250-500M (estimated)

Primary capability

Electronics & Software

Certifications

ISO 13485 · ISO 14001 · ISO 9001

What Otsuka Pharmaceutical Companies Europe makes

Otsuka maintains ISO 13485, ISO 14001, and ISO 9001 certifications and delivers specialty pharmaceuticals for neuroscience, nephrology, and haemato-oncology, alongside digital health solutions.

Certifications

Otsuka Pharmaceutical Companies Europe is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Latest developments

Facilities

Otsuka Pharmaceutical Companies Europe is headquartered in Slough, England. Public sources also reference these locations:

Company details

The company operates across France, Germany, and England, serving unmet medical needs in specialty pharmaceuticals and clinical nutrition within European healthcare markets. Otsuka Pharmaceutical Companies Europe was founded in 1979, has an estimated 500-1,000 employees, and is headquartered in Slough, England. On the LightSource stability read it is rated "Established & active": 47 years in operation (founded 1979). Holds ISO 13485, ISO 14001, ISO 9001 certification(s) per public sources.

Frequently asked questions

What does Otsuka Pharmaceutical Companies Europe make?

Otsuka Pharmaceutical Europe Ltd. is the European regional headquarters for Japan-based Otsuka Pharmaceutical Co., Ltd., operating from Slough, England since its UK establishment in 1998. The private company employs 500–1,000 staff and generates estimated revenues of $250–500M annually. It develops and distributes pharmaceuticals, nutraceutical products, and clinical nutrition solutions across Europe, focusing on cardiovascular, gastrointestinal, and central nervous system disorders. In January 2026, the company obtained European Union marketing authorization for donidalorsen to treat hereditary angioedema.

Where is Otsuka Pharmaceutical Companies Europe headquartered?

Otsuka Pharmaceutical Companies Europe is headquartered in Slough, England.

When was Otsuka Pharmaceutical Companies Europe founded?

Otsuka Pharmaceutical Companies Europe was founded in 1979.

How big is Otsuka Pharmaceutical Companies Europe?

Otsuka Pharmaceutical Companies Europe has an estimated 500-1,000 employees, with revenue in the $250-500M range (estimated).

What certifications does Otsuka Pharmaceutical Companies Europe hold?

Otsuka Pharmaceutical Companies Europe lists ISO 13485 · ISO 14001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Slough, England (HQ)Headquarters · England, United Kingdom
Slough, England (HQ)Slough, England, United KingdomHeadquarters

Phone

'+44 20 3747 5000

Certification

ISO 13485 · ISO 14001 · ISO 9001

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.